Cerus (CERS) Cash from Operations (2010 - 2026)
Cerus (CERS) reported Cash from Operations of 3049000.0 for Q1 2026, down 261.26% on a YoY basis from 1890783.25 in Q1 2025, and down 149.18% sequentially from 6200000.0 in Q4 2025.
Cerus (CERS) Cash from Operations (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Cash from Operations data on file, last reported at 3049000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 261.26% year-over-year to 3049000.0; the trailing twelve-month figure through Mar 2026 stood at 2632000.0 (down 69.24% YoY), and the FY2025 full-year result was 4837000.0, down 57.42% from the prior year.
- Cash from Operations slipped to 3049000.0 in Q1 2026, from 6200000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 6200000.0 in Q4 2025 to a low of 21456000.0 in Q1 2022.
- A 5-year average of 3272705.88 and a median of 1756000.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 2507.54% in 2023 and jumped 138.8% in 2024, its largest moves.
- Tracing CERS's Cash from Operations over 5 years: stood at 1756000.0 in 2022, then plunged by 764.64% to 15183000.0 in 2023, then soared by 132.46% to 4929000.0 in 2024, then climbed by 25.79% to 6200000.0 in 2025, then plunged by 149.18% to 3049000.0 in 2026.
- Business Quant data shows CERS's Cash from Operations at 3049000.0 in Q1 2026, 6200000.0 in Q4 2025, and 1927000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 525.60 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 290.00 Mn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | 220.10 Mn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.05 Mn |
| Mar 31, 2026 | -3.05 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | -2.45 Mn |
| Jun 30, 2025 | -2.45 Mn |
| Mar 31, 2025 | -844,000.00 |
| Mar 31, 2025 | -844,000.00 |
| Dec 31, 2024 | 4.93 Mn |
| Dec 31, 2024 | 4.93 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 401,000.00 |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | -15.18 Mn |
| Dec 31, 2023 | -15.18 Mn |